« FDA Approves Doribax | Main | Stock Market Fluctuations in Big Pharmas as of October 19, 2007 »

Oct19
What is Crohn's Disease

Crohn's disease, also know as regional enteritis) is an inflammatory bowel disease (IBS) and not irritable bowel syndrome as some people think. Crohn's is an infection anywhere from the top of the esophagus to the rectum whereas IBS is normally limited to the intestines and colon.

There is no known cause for Crohn's disease is a virus or chronic condition that researchers consider an auto-immune disease, The body itself causes the conditions needed for a flare-up.

Crohns.jpgSymptoms of Crohn's include painful abdominal cramping, frequent bowel movements, diarrhea, joint pain and fatigue. It can occur at any age but normally presents itself between the ages of 15 and 30 and usually in Caucasian women.

Treatment includes diet, exercise, antibiotics and salicylates for mild cases and steroids or immunomodulators for those with a more severe form of the disease. Newer biological medications are also available like inflixmab and Abbott Laboratories' Humira.

While not fatal the disease is chronic and as is often cyclical with periods of improvement followed by relapses.

 


2 Comments/Trackbacks




» Cimzia Approved by FDA to Treat Crohn's Disease from PharmaGazette
The U.S Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of moderate to serve Crohn's disease in adults who have not responded to other therapies."Crohn's is a debilitating disease that disrupts the q... [Read More]

» Humira, Remicade and Enbrel Under FDA Review for Cancer Link from PharmaGazette
  The U.S. Food and Drug Administration announced that it is investigating whether a group of arthritis drugs increase the risk of pediatric cancer. The group of drugs include Abbott Laboratories' Humira, Schering-Plough's Remicade an... [Read More]

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« FDA Approves Doribax | Main | Stock Market Fluctuations in Big Pharmas as of October 19, 2007 »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb